Lexicon Pharmaceuticals, Inc.
HealthcareNASDAQ:LXRX · NASDAQ Global Select
+$0.03 today
Vol 2.99M · Avg 2.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+185.93%
Period High
$2.44
Period Low
$0.67
Latest
$1.92
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Omeros Corporation
NASDAQ:OMER
$632.20M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$461.60M
Ocugen, Inc.
NASDAQ:OCGN
$409.61M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$329.81M
Bicycle Therapeutics plc
NASDAQ:BCYC
$281.05M
Compass Therapeutics, Inc.
NASDAQ:CMPX
$280.72M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$186.68M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
Gossamer Bio, Inc.
GOSS
$38.00M
What is the latest LXRX filing?
The latest filing shown is 4 dated Jun 4, 2026.
How many recent filings does LXRX have?
Intrinsic Alpha currently shows 20 recent filings for LXRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.